{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:03:56Z","timestamp":1779365036099,"version":"3.53.0"},"reference-count":73,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-14-0032"],"award-info":[{"award-number":["APVV-14-0032"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Huntington\u2019s disease (HD) is an inherited, autosomal dominant, degenerative disease characterized by involuntary movements, cognitive decline, and behavioral impairment ending in death. HD is caused by an expansion in the number of CAG repeats in the huntingtin gene on chromosome 4. To date, no effective therapy for preventing the onset or progression of the disease has been found, and many symptoms do not respond to pharmacologic treatment. However, recent results of pre-clinical trials suggest a beneficial effect of stem-cell-based therapy. Induced pluripotent stem cells (iPSCs) represent an unlimited cell source and are the most suitable among the various types of autologous stem cells due to their patient specificity and ability to differentiate into a variety of cell types both in vitro and in vivo. Furthermore, the cultivation of iPSC-derived neural cells offers the possibility of studying the etiopathology of neurodegenerative diseases, such as HD. Moreover, differentiated neural cells can organize into three-dimensional (3D) organoids, mimicking the complex architecture of the brain. In this article, we present a comprehensive review of recent HD models, the methods for differentiating HD\u2013iPSCs into the desired neural cell types, and the progress in gene editing techniques leading toward stem-cell-based therapy.<\/jats:p>","DOI":"10.3390\/ijms21062239","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T07:16:08Z","timestamp":1585034168000},"page":"2239","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Recent Overview of the Use of iPSCs Huntington\u2019s Disease Modeling and Therapy"],"prefix":"10.3390","volume":"21","author":[{"given":"Maria","family":"Csobonyeiova","sequence":"first","affiliation":[{"name":"Institute of Histology and Embryology, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Polak","sequence":"additional","affiliation":[{"name":"Institute of Histology and Embryology, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5074-9621","authenticated-orcid":false,"given":"Lubos","family":"Danisovic","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia"},{"name":"Regenmed Ltd., Medena 29, 811 01 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mcn.2013.02.005","article-title":"Modeling Huntington\u2019s disease with induced pluripotent stem cells","volume":"56","author":"Kaye","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-6606-5-17","article-title":"Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington\u2019s disease patient cells","volume":"5","author":"Juopperi","year":"2012","journal-title":"Mol. Brain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11910-017-0739-9","article-title":"Huntington\u2019s Disease-Update on Treatments","volume":"17","author":"Wyant","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington\u2019s disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pneurobio.2016.01.006","article-title":"The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders","volume":"157","author":"Smith","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington\u2019s disease 6 years after surgery: A long-term follow-up study","volume":"5","author":"Gaura","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jgg.2012.04.006","article-title":"Pluripotent stem cells models for Huntington\u2019s disease: Prospects and challenges","volume":"39","author":"Carter","year":"2012","journal-title":"J. Genet. Genom."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1590\/s1980-5764-2016dn1004006","article-title":"Cell-based technologies for Huntington\u2019s disease","volume":"10","author":"Haddad","year":"2016","journal-title":"Dement. Neuropsychol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.drudis.2014.02.012","article-title":"Cell-based therapies for Huntington\u2019s disease","volume":"19","author":"Chen","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/bs.pbr.2016.12.011","article-title":"From open to large-scale randomized cell transplantation trials in Huntington\u2019s disease: Lessons from the multicentric intracerebral grafting in Huntington\u2019s disease trial (MIG-HD) and previous pilot studies","volume":"230","year":"2017","journal-title":"Prog. Brain Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.lfs.2018.07.030","article-title":"Human cellular models of medium spiny neuron development and Huntington disease","volume":"209","author":"Golas","year":"2018","journal-title":"Life Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zhang, N., An, M.C., Montoro, D., and Ellerby, L.M. (2010). Characterization of Human Huntington\u2019s Disease Cell Model from Induced Pluripotent Stem Cells. PLoS Curr., 2.","DOI":"10.1371\/currents.RRN1193"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2011.12.042","article-title":"The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington\u2019s disease patients demonstrates mutation related enhanced lysosomal activity","volume":"46","author":"Camnasio","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/gt.2011.170","article-title":"Using non-coding small RNAs to develop therapies for Huntington\u2019s disease","volume":"18","author":"Zhang","year":"2011","journal-title":"Gene Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4939-7825-0_4","article-title":"Cellular Models: HD Patient-Derived Pluripotent Stem Cells","volume":"1780","author":"Geater","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Csobonyeiova, M., Polak, S., Zamborsky, R., and Danisovic, L. (2019). Recent Progress in the Regeneration of Spinal Cord Injuries by Induced Pluripotent Stem Cells. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153838"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12015-013-9441-8","article-title":"Human pluripotent stem cell differentiation into authentic striatal projection neurons","volume":"9","author":"Onorati","year":"2013","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1093\/hmg\/ddv318","article-title":"Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington\u2019s disease iPSCs","volume":"24","author":"Chiu","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1093\/hmg\/ddx327","article-title":"FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington\u2019s disease and their derived neural cells","volume":"26","author":"Liu","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.stemcr.2014.07.011","article-title":"Reversal of cellular phenotypes in neural cells derived from Huntington\u2019s disease monkey-induced pluripotent stem cells","volume":"3","author":"Carter","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cho, I.K., Yang, B., Forest, C., Qian, L., and Chan, A.W.S. (2019). Amelioration of Huntington\u2019s disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington\u2019s disease monkeys. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0214156"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-016-0092-5","article-title":"Manifestation of Huntington\u2019s disease pathology in human induced pluripotent stem cell-derived neurons","volume":"11","author":"Nekrasov","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.expneurol.2013.09.024","article-title":"Modeling neurodegenerative diseases in Caenorhabditis elegans","volume":"250","author":"Li","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1042\/BST20120072","article-title":"Choosing and using Drosophila models to characterize modifiers of Huntington\u2019s disease","volume":"40","author":"Green","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/hmg\/ddq313","article-title":"Expression of Huntington\u2019s disease protein results in apoptotic neurons in the brains of cloned transgenic pigs","volume":"19","author":"Yang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"Dmm.041319","DOI":"10.1242\/dmm.041319","article-title":"Transgenic minipig model of Huntington\u2019s disease exhibiting gradually progressing neurodegeneration","volume":"13","author":"Ardan","year":"2019","journal-title":"Dis. Models Mech."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12035-012-8315-4","article-title":"Mouse models of polyglutamine diseases: Review and data table. Part I","volume":"46","author":"Figiel","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12035-012-8316-3","article-title":"Mouse models of polyglutamine diseases in therapeutic approaches: Review and data table. Part II","volume":"46","author":"Switonski","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nature06975","article-title":"Towards a transgenic model of Huntington\u2019s disease in a non-human primate","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"ref_31","first-page":"2179","article-title":"Transgenic animal models for study of the pathogenesis of Huntington\u2019s disease and therapy","volume":"9","author":"Chang","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Bordoni, M., Rey, F., Fantini, V., Pansarasa, O., Di Giulio, A.M., Carelli, S., and Cereda, C. (2018). From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123972"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fnins.2017.00628","article-title":"Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington\u2019s Disease","volume":"11","author":"Culver","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_34","first-page":"1047","article-title":"Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway","volume":"8","author":"Szlachcic","year":"2015","journal-title":"Dis. Models Mech."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fncel.2018.00528","article-title":"Identification of Altered Developmental Pathways in Human Juvenile HD iPSC With 71Q and 109Q Using Transcriptome Profiling","volume":"12","author":"Szlachcic","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/2472555216685044","article-title":"Induced Pluripotent HD Monkey Stem Cells Derived Neural Cells for Drug Discovery","volume":"22","author":"Kunkanjanawan","year":"2017","journal-title":"SLAS Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41536-019-0066-7","article-title":"Combination of stem cell and gene therapy ameliorates symptoms in Huntington\u2019s disease mice","volume":"4","author":"Cho","year":"2019","journal-title":"NPJ Regen. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1172\/JCI70911","article-title":"Inhibition of mitochondrial fragmentation diminishes Huntington\u2019s disease-associated neurodegeneration","volume":"123","author":"Guo","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2174\/138161208784480117","article-title":"A critical evaluation of adenosine A2A receptors as potentially \u201cdruggable\u201d targets in Huntington\u2019s disease","volume":"14","author":"Popoli","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fncel.2019.00129","article-title":"Organs to Cells and Cells to Organoids: The Evolution of in vitro Central Nervous System Modelling","volume":"13","author":"Pacitti","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"180177","DOI":"10.1098\/rsob.180177","article-title":"Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease","volume":"9","author":"Wu","year":"2019","journal-title":"R. Soc. Open Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"165431","DOI":"10.1016\/j.bbadis.2019.03.004","article-title":"Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases","volume":"1866","author":"Zhang","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/nprot.2014.158","article-title":"Generation of cerebral organoids from human pluripotent stem cells","volume":"9","author":"Lancaster","year":"2014","journal-title":"Nat. Protoc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.biomaterials.2013.11.028","article-title":"A 3D Alzheimer\u2019s disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Raja, W.K., Mungenast, A.E., Lin, Y.T., Ko, T., Abdurrob, F., Seo, J., and Tsai, L.H. (2016). Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer\u2019s Disease Phenotypes. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161969"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/nan.12396","article-title":"Distinctive genomic signature of neural and intestinal organoids from familial Parkinson\u2019s disease patient-derived induced pluripotent stem cells","volume":"43","author":"Son","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.stemcr.2019.01.020","article-title":"Modeling G2019S-LRRK2 Sporadic Parkinson\u2019s Disease in 3D Midbrain Organoids","volume":"12","author":"Kim","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41398-018-0122-x","article-title":"Shared effects of DISC1 disruption and elevated WNT signaling in human cerebral organoids","volume":"8","author":"Srikanth","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.celrep.2017.03.047","article-title":"An Organoid-Based Model of Cortical Development Identifies Non-Cell-Autonomous Defects in Wnt Signaling Contributing to Miller-Dieker Syndrome","volume":"19","author":"Iefremova","year":"2017","journal-title":"Cell Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"E762","DOI":"10.1073\/pnas.1715865115","article-title":"Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes","volume":"115","author":"Conforti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zhang, J., Ooi, J., Utami, K.H., Langley, S.R., Aning, O.A., Park, D.S., Renner, M., Ma, S., Cheok, C.F., and Knoblich, J.A. (2020). Expanded huntingtin CAG repeats disrupt the balance between neural progenitor expansion and differentiation in human cerebral organoids. bioRxiv, 850586.","DOI":"10.1101\/850586"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.stem.2015.03.004","article-title":"Vascularized and Complex Organ Buds from Diverse Tissues via Mesenchymal Cell-Driven Condensation","volume":"16","author":"Takebe","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nbt.4127","article-title":"An in vivo model of functional and vascularized human brain organoids","volume":"36","author":"Mansour","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1038\/s41467-018-06684-2","article-title":"Microglia innately develop within cerebral organoids","volume":"9","author":"Ormel","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nn.4534","article-title":"Differentiation of human and murine induced pluripotent stem cells to microglia-like cells","volume":"20","author":"Pandya","year":"2017","journal-title":"Nat. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"12516","DOI":"10.1073\/pnas.1516645112","article-title":"Human pluripotent stem cell-derived neural constructs for predicting neural toxicity","volume":"112","author":"Schwartz","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Costamagna, G., Andreoli, L., Corti, S., and Faravelli, I. (2019). iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery. Cells, 8.","DOI":"10.3390\/cells8111438"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/d41586-018-05380-x","article-title":"Stem-cell culture moves to the third dimension","volume":"558","author":"Tachibana","year":"2018","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI45130","article-title":"Oligonucleotide therapeutic approaches for Huntington disease","volume":"121","author":"Sah","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin","volume":"19","author":"Carroll","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","article-title":"CRISPR\/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo","volume":"25","author":"Monteys","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_66","first-page":"4566","article-title":"Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9","volume":"25","author":"Shin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1172\/JCI92087","article-title":"CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kolli, N., Lu, M., Maiti, P., Rossignol, J., and Dunbar, G.L. (2017). CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington\u2019s Disease. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18040754"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin Lowering Strategies for Disease Modification in Huntington\u2019s Disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cge.12385","article-title":"Personalized gene silencing therapeutics for Huntington disease","volume":"86","author":"Kay","year":"2014","journal-title":"Clin. Genet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrn.2017.107","article-title":"The use of brain organoids to investigate neural development and disease","volume":"18","author":"Kriegstein","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nmeth.4304","article-title":"Fused cerebral organoids model interactions between brain regions","volume":"14","author":"Bagley","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature09805","article-title":"Somatic coding mutations in human induced pluripotent stem cells","volume":"471","author":"Gore","year":"2011","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/6\/2239\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:11:00Z","timestamp":1760173860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/6\/2239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":73,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["ijms21062239"],"URL":"https:\/\/doi.org\/10.3390\/ijms21062239","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]}}}